Community-acquired pneumonia: Incidence, epidemiology, and current therapeutic management

Improved microbiological techniques have led to the realization that as many as 30% of patients diagnosed with community-acquired pneumonia (CAP) are infected with atypical respiratory pathogens. Furthermore, antimicrobial resistance among isolates of Streptococcus pneumoniae, the leading cause of CAP, has skyrocketed in recent years. These 2 factors have contributed to the need for a reevaluation of optimal patient care.